Detail page

Knowledge Web

Person

Isabell Witzel (1975-)

Gynäkologin

Name	Isabell Witzel
Time	1975- (Date of birth and death)
Gender	weiblich
Academic degree	Priv.-Doz. Dr.
Profession	Gynäkologin (characteristic profession) Ärztin
Variant	Isabell Diana Witzel Isabell D. Witzel I. Witzel
Related	Universitätsklinikum Hamburg-Eppendorf
Further information	Diss. Fachbereich Medizin Univ. Hamburg, Medizinische Fak., Universitätsklinikum Hamburg-Eppendorf, Zentrum für Operative Medizin, Klinik und Poliklinik für Gynäkologie, Oberärztin am Brustzentrum
Record type	Person
GND-Identifier	12484071X
Record ID	12484071X
Involved in show all Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024 Update breast cancer 2024 part 1 - expert opinion on advanced breast cancer Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021 Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer Detektion und Charakterisierung tumorassoziierter Zellen und Zellcluster im Blut von Brustkrebspatientinnen Die klinische Bedeutung proliferierender CD8 positiver zytotoxische Lymphozyten beim Mammakarzinom Die Wirkung von grünem Tee und seinen Bestandteilen Epigallocatechingallat (EGCG), Quercetin und Rutin im Vergleich sowie in Kombination mit Endoxifen auf maligne Mammakarzinomzelllinien (MCF-7 und MDA-MB-231) Hirnmetastasen beim Mammakarzinom : Auftreten, Therapie und Prognose der letzten 10 Jahre : Zuarbeit zur Studie GBG79 Brainmet Register aus den Daten des Tumorzentrums Gera Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry - comparison of three different GPA prognostic scores Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores Referenz Gynäkologie AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2020 AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020 Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases Einfluss von Allium porrum - Extrakt (Lauch) im Vergleich zu synthetischem Quercetin und Rutin auf benigne und normale hormonrezeptorpositive und -negative Mammazellen Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: Update 2019 Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial Clinical relevance of collagen protein degradation markers c3m and c4m in the serum of breast cancer patients treated with neoadjuvant therapy in the geparquinto trial Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy : the German experience Untersuchungen zur Wirkung von vier verschiedenen kommerziellen Lignanen auf humane Mammaepithelzellen Retrospektive Analyse zur Identifikation von Prognosefaktoren für den Sentinel- und Non-Sentinel-Lymphknoten-Status beim invasiven Mammakarzinom Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy: the German experience Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry Prognostische und prädiktive Bedeutung von HER-2-neu im Serum bei Patientinnen mit metastasiertem Mammakarzinom unter palliativer Chemotherapie (Epirubicin-Paclitaxel versus Epirubicin-Cyclophosphamid) Prognostische und prädiktive Bedeutung von HER-2-neu im Serum bei Patientinnen mit metastasiertem Mammakarzinom unter palliativer Chemotherapie (Epirubicin-Paclitaxel versus Epirubicin-Cyclophosphamid)

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Isabell Witzel (1975-)

Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024

Update breast cancer 2024 part 1 - expert opinion on advanced breast cancer

Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021

Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer

Detektion und Charakterisierung tumorassoziierter Zellen und Zellcluster im Blut von Brustkrebspatientinnen

Die klinische Bedeutung proliferierender CD8 positiver zytotoxische Lymphozyten beim Mammakarzinom

Die Wirkung von grünem Tee und seinen Bestandteilen Epigallocatechingallat (EGCG), Quercetin und Rutin im Vergleich sowie in Kombination mit Endoxifen auf maligne Mammakarzinomzelllinien (MCF-7 und MDA-MB-231)

Hirnmetastasen beim Mammakarzinom : Auftreten, Therapie und Prognose der letzten 10 Jahre : Zuarbeit zur Studie GBG79 Brainmet Register aus den Daten des Tumorzentrums Gera

Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry - comparison of three different GPA prognostic scores

Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores

Referenz Gynäkologie

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2020

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020

Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases

Einfluss von Allium porrum - Extrakt (Lauch) im Vergleich zu synthetischem Quercetin und Rutin auf benigne und normale hormonrezeptorpositive und -negative Mammazellen

Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: Update 2019

Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial

Clinical relevance of collagen protein degradation markers c3m and c4m in the serum of breast cancer patients treated with neoadjuvant therapy in the geparquinto trial

Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy : the German experience

Untersuchungen zur Wirkung von vier verschiedenen kommerziellen Lignanen auf humane Mammaepithelzellen

Retrospektive Analyse zur Identifikation von Prognosefaktoren für den Sentinel- und Non-Sentinel-Lymphknoten-Status beim invasiven Mammakarzinom

Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy: the German experience

Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry

Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry

Prognostische und prädiktive Bedeutung von HER-2-neu im Serum bei Patientinnen mit metastasiertem Mammakarzinom unter palliativer Chemotherapie (Epirubicin-Paclitaxel versus Epirubicin-Cyclophosphamid)

Prognostische und prädiktive Bedeutung von HER-2-neu im Serum bei Patientinnen mit metastasiertem Mammakarzinom unter palliativer Chemotherapie (Epirubicin-Paclitaxel versus Epirubicin-Cyclophosphamid)